However, the results of our pilot study are in support of SIRT1’s tumor suppressor role in canine mammary gland cancer, as we showed, for the first time, reduced immunoexpression and a shift from nuclear to cytoplasmic localization, which was linked to increasing grades of malignancy. This evidence concerns the gene SIRT1 and neoplasm.